These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11159714)

  • 41. T cell reactions in patients showing adverse immune reactions to drugs.
    Zanni MP; von Greyerz S; Schnyder B; Mauri-Hellweg D; Brander C; Kalbermatten C; Pichler WJ
    Inflamm Res; 1996 Dec; 45 Suppl 2():S79-84. PubMed ID: 8988407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
    Leeder JS; Dosch HM; Spielberg SP
    Biochem Pharmacol; 1991 Feb; 41(4):567-74. PubMed ID: 1997005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of pokeweed mitogen-driven human IgM and IgG responses by the hydroxylamine of sulfamethoxazole.
    Sisson ME; Rieder MJ; Bird IA; Almawi WY
    Int J Immunopharmacol; 1997 May; 19(5):299-304. PubMed ID: 9439768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo.
    Tailor A; Waddington JC; Hamlett J; Maggs J; Kafu L; Farrell J; Dear GJ; Whitaker P; Naisbitt DJ; Park K; Meng X
    Chem Res Toxicol; 2019 Oct; 32(10):2095-2106. PubMed ID: 31468968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole.
    Gruchalla RS; Pesenko RD; Do TT; Skiest DJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
    Vyas PM; Roychowdhury S; Woster PM; Svensson CK
    Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
    Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK
    Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
    Zhao Q; Alhilali K; Alzahrani A; Almutairi M; Amjad J; Liu H; Sun Y; Sun L; Zhang H; Meng X; Gibson A; Ogese MO; Kevin Park B; Liu J; Ostrov DA; Zhang F; Naisbitt DJ
    Allergy; 2019 Aug; 74(8):1533-1548. PubMed ID: 30844087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.
    Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition.
    Watkins S; Pichler WJ
    PLoS One; 2013; 8(10):e76211. PubMed ID: 24116097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors.
    Gibson A; Faulkner L; Lichtenfels M; Ogese M; Al-Attar Z; Alfirevic A; Esser PR; Martin SF; Pirmohamed M; Park BK; Naisbitt DJ
    J Immunol; 2017 Aug; 199(4):1223-1237. PubMed ID: 28687658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines.
    Rieder MJ; Sisson E; Bird IA; Almawi WY
    Int J Immunopharmacol; 1992 Oct; 14(7):1175-80. PubMed ID: 1452402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct photolysis of human metabolites of the antibiotic sulfamethoxazole: evidence for abiotic back-transformation.
    Bonvin F; Omlin J; Rutler R; Schweizer WB; Alaimo PJ; Strathmann TJ; McNeill K; Kohn T
    Environ Sci Technol; 2013 Jul; 47(13):6746-55. PubMed ID: 23186099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells.
    Adeyanju K; Bend JR; Rieder MJ; Dekaban GA
    Virol J; 2018 May; 15(1):82. PubMed ID: 29743079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System.
    Ali SE; Meng X; Kafu L; Hammond S; Zhao Q; Ogese M; Sison-Young R; Jones R; Chan B; Livoti L; Sun Y; Sun L; Liu H; Topping A; Goldring C; Zhang F; Naisbitt DJ
    Chem Res Toxicol; 2023 Mar; 36(3):390-401. PubMed ID: 36812109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function.
    Gibson A; Ogese M; Sullivan A; Wang E; Saide K; Whitaker P; Peckham D; Faulkner L; Park BK; Naisbitt DJ
    J Immunol; 2014 Mar; 192(6):2611-2621. PubMed ID: 24510967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
    Cribb AE; Spielberg SP; Griffin GP
    Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat.
    Cribb AE; McQuaid T; Renton KW
    Biochem Pharmacol; 2001 Aug; 62(4):457-9. PubMed ID: 11448455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-course of toxicity of reactive sulfonamide metabolites.
    Rieder MJ; Krause R; Bird IA
    Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.